Clinical trial
Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission: a Randomized Clinical Trial Comparing Early Versus Late Drug Withdrawal Combining Imaging and Multi-Omics
NCT06618937 is registered in ClinicalTrials.gov with Istituto Giannina Gaslini as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Toward Personalized Medicine to Guide Drug Withdrawal in Children with Juvenile Idiopathic Arthritis in Clinical Remission: a Randomized Clinical Trial Comparing Early Versus Late Drug Withdrawal Combining Imaging and Multi-Omics
- Lead sponsor
- Istituto Giannina Gaslini
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- January 1, 2025
- Completion date
- January 1, 2029
- Enrollment
- 166 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
juvenile idiopathic arthritis (jia)